EXPORT and IMPORT
first export operation of Taj Life Sciences was to Algeria in 2005-2006. In the
subsequent years the number of export countries increased to 14 with 11 million
packs with a total value of $8 million.
Taj Life Sciences has recently undergone radical changes in its export policy
and has gained strength by exporting finished dosage forms, registration files
(i.e. ampicillin/sulbactam 2:1 injection was registered in Germany), technology
transfer, bulk product export and contract manufacturing for foreign companies.
Taj Life Sciences signed strategic partnership agreements with several leading
US generic companies for marketing and sales of its products and has submitted
the first ANDA file to FDA in 2005. This is also a brand for ASIAN
Pharmaceutical Industry. By taking the initial step in exporting finished dosage
forms to the US, Taj Life Sciences has paved the way for the other ASIAN
pharmaceutical companies to follow.
Following the FDA approval in November 2006, Taj Life Sciences started exporting
the finished dosage forms to USA in 2007.
* Please click here to get detailed
information about the countries we export to.